Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Collaborative Ocular Antiangiogenic Study of Ukraine. Multicentral, Open-label, Randomized, Prospective Study of Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Pathologic Myopia

NCT04976244 is registered in ClinicalTrials.gov with The Filatov Institute of Eye Diseases and Tissue Therapy as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04976244 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Collaborative Ocular Antiangiogenic Study of Ukraine. Multicentral, Open-label, Randomized, Prospective Study of Antiangiogenic Therapy of Choroidal Neovascularisation Associated With Pathologic Myopia
Lead sponsor
The Filatov Institute of Eye Diseases and Tissue Therapy
Phase
Not applicable
Overall status
Unknown status
Start date
April 1, 2021
Completion date
April 1, 2022
Enrollment
50 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

pathologic myopia